Recipharm and PLG team up to streamline development and approvals

Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) have joined forces in a move aimed at speeding up the route to clinical trials and approvals for pharma and biotech companies.

The collaboration brings together Recipharm’s drug development and manufacturing network with PLG’s global regulatory affairs, pharmacovigilance, and market access services. The companies say their strategic tie-up will help customers cut through the growing complexity of the regulatory landscape while reducing supply chain and compliance hurdles.

Recipharm’s customers will now be able to tap into PLG’s network of 2,000 regulatory experts across 150 countries. The deal sets the stage for a more integrated approach to drug development—right from the start of the pipeline.